Food restriction (FR) and obesogenic (OB) diets are known to alter brain dopamine transmission and exert opposite modulatory effects on behavioral responsiveness to psychostimulant drugs of abuse. Mechanisms underlying these diet effects are not fully understood. In this study, we examined diet effects on expression and function of the dopamine transporter (DAT) in caudate-putamen (CPu), nucleus accumbens (NAc), and midbrain regions. Dopamine (DA) uptake by CPu, NAc or midbrain synapto(neuro)somes was measured in vitro with rotating disk electrode voltammetry or with [ 3 H]DA uptake and was found to correlate with DAT surface expression, assessed by maximal [ 3 H](-)-2-b-carbomethoxy-3-b-(4-fluorophenyl)tropane binding and surface biotinylation assays. FR and OB diets were both found to decrease DAT activity in CPu with a corresponding decrease in surface expression but had no effects in the NAc and midbrain. Diet treatments also affected sensitivity to insulin-induced enhancement of DA uptake, with FR producing an increase in CPu and NAc, likely mediated by an observed increase in insulin receptor expression, and OB producing a decrease in NAc. The increased expression of insulin receptor in NAc of FR rats was accompanied by increased DA D 2 receptor expression, and the decreased DAT expression and function in CPu of OB rats was accompanied by decreased DA D 2 receptor expression. These results are discussed as partial mechanistic underpinnings of diet-induced adaptations that contribute to altered behavioral sensitivity to psychostimulants that target the DAT.
Evidence obtained from animal models and human neuroimaging indicate that brain dopamine function can be altered by diet and body weight (Carr 2011; Val-Laillet et al. 2015; D ecarie-Spain et al. 2016) . Insofar as brain dopamine regulates such behavioral functions as reward learning (Schultz 1998) , incentive motivation (Berridge 2007) , and nutritive signaling (Tellez et al. 2016) , diet-induced changes can be adaptive, for example, when up-regulated to promote appetitive behavior during periods of food scarcity and negative energy balance. On the other hand, changes that accompany excessive consumption of energy-dense, highly palatable foods may perpetuate and exacerbate maladaptive behavior, including compulsive eating (Johnson and Kenny 2010) . One of the specific molecular targets of diet-induced regulation is very likely the dopamine transporter (DAT) which functions to clear extracellular dopamine (DA), thereby contributing to the balance of dopaminergic tone.
Evidence that points to DAT regulation by diet includes the many demonstrations that rewarding and locomotor-activating effects of psychostimulant drugs, including cocaine and (meth)amphetamine which target the DAT (Rice and Cragg 2008; Sulzer 2011) , are modified by underfeeding and overfeeding (Carroll and Meisch 1984; Pothos et al. 1995; Wellman et al. 2007; Davis et al. 2008; Geiger et al. 2009; Zheng et al. 2012) . Generally, the cellular and behavioral responsiveness to these psychostimulants are increased with food restriction (Carroll et al. 1981; Pothos et al. 1995; Bell et al. 1997; Cabeza de Vaca and Carr 1998; Carr 2011; Zheng et al. 2012) , but decreased with an obesogenic diet (Davis et al. 2008; Speed et al. 2011; Hryhorczuk et al. 2016) . The relationship between diet and DAT-dependent psychostimulant effects may be mediated by changes in insulin exposure. Chronically food-restricted animals are hypoinsulinemic, obese animals are hyperinsulinemic (Banks et al. 2012; Stouffer et al. 2015) , and insulin levels in the brain parallel levels in the periphery (Strubbe et al. 1988; Banks 2004) . Furthermore, insulin, by acting on insulin receptors (InsR), activates the PI3K/Akt signaling cascade which in turn enhances the surface expression of DAT and hence its overall uptake capacity (Carvelli et al. 2002; Garcia et al. 2005; Speed et al. 2011 ). Changes in brain insulin level and InsR sensitivity under different dietary conditions may therefore be important factors in determining DAT function, DA signaling, and both adaptive and maladaptive behavior directed toward food and drugs of abuse. While the rationale for presuming DAT as the mediator of diet-related differences in effects of DAT ligands seems well-founded, it is clear that other components of DA neurotransmission can also vary in relation to diet. DA release is one such component, with extracellular DA levels reflecting a balance between impulseflow induced DA release and DAT-mediated DA clearance (Wu et al. 2001; Stouffer et al. 2015) .
Recently, we found that activation of InsRs by exogenous insulin applied to striatal slices potentiates evoked DA release in both caudate-putamen (CPu) and nucleus accumbens (NAc), with a greater effect in the latter rather than the former (Stouffer et al. 2015 ). This regional difference may be because of the higher expression levels of InsR in the NAc (Schulingkamp et al. 2000) . Notably, we found that the primary function of insulin under depolarized conditions was to stimulate striatal DA release in spite of a parallel increase in DAT activity (V max ) as estimated in a computational method applied to the time course of DA clearance as in our previous work (Wu et al. 2001 ). Insulin's effect on release and uptake was lost at supraphysiological concentrations (100 nM), arguing against insulin-enhanced uptake dominating the balance between release and uptake (Stouffer et al. 2015) . While both food restriction and an obesogenic diet decreased evoked DA release at baseline, they induced opposite changes in sensitivity to insulin's amplifying effect on DA release, with food restriction enhancing and obesogenic diet diminishing (Stouffer et al. 2015) . Understanding diet-and insulin-induced changes in DAT function in situ is a necessary part of unraveling the mechanistic basis of diet-induced changes in DA transmission, psychostimulant responsiveness, and feeding behavior. Consequently, this study was undertaken to experimentally obtain kinetic parameters and functional expression of DAT with intent to complement previous in silico derived V max values that required the input of an assumed K m value (Stouffer et al. 2015) . We hypothesized that DAT function would change in a corresponding manner to our DA release findings and may further exhibit regional differences. To examine the influence of diet and insulin on DAT functionality we measured DATmediated DA transport, functional expression of DAT protein at the plasma membrane via biotinylation assays and [ 3 H](-)-2-b-carbomethoxy-3-b-(4-fluorophenyl)tropane (CFT) binding, and total expression via Western blotting in striatal subregions and the DA cell body area originating from the midbrain. We also examined the effect of diet on InsR and DA D 2 receptor (D 2 R) expression in striatal subregions and midbrain. Here we find that DAT activity in vitro is affected across feeding groups and differs in response to exogenous insulin in a regionally specific manner.
Materials and methods

Animals
Procedures were in accordance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the NYU School of Medicine Animal Care and Use Committee. In preparing the present work for publication, the guide for ethical behavior in publishing research was followed as described in the COPE Report 2003 [available from the Committee on Publication Ethics (COPE)].
Adult male Sprague-Dawley rats (8-10 weeks; Taconic, New York, NY, USA) were singly housed for all diet comparisons on 12 h light : dark cycle (lights on 0600).
Rat diet regimen
Dietary changes were initiated when subjects were between 9 and 12 weeks of age and the duration of the ad libitum, obesitypromoting (Levin and Keesey 1998) or food restricted (Carr et al. 2001 ) diets was 25-30 days. Ad libitum (AL) fed subjects were given free access to LabDiet 5001 standard rat chow (LabDiet, St. Louis, MO, USA) from which 29.8% of calories are provided by protein, 13.4% from fat, and 56.7% from carbohydrate, 6% of which are from sugars. A typical daily intake was 25 grams with a yield of 84 kcal of physiological fuel value. In food-restricted (FR) rats, the daily allotment of rat chow was decreased by 50-60% to 10 g per day until body weight decreased by 20% (approximately 2-3 weeks). Daily feeding was then titrated to maintain stability of new body weight for the remaining days (Carr et al. 2001) . Subjects on the obesogenic (OB) diet had ad libitum access to rat chow and Milk Chocolate Ensure (Abbott Laboratories, Lake Forest, IL, USA) (Levin and Keesey 1998) from which 23% of calories are provided by fat and 27% from sugar. Within 1 week of initiating Ensure availability, OB rats consumed negligible amounts of chow and, on average, consumed 135 mL of Ensure per day with a yield of 126 kcal.
The different diet groups were equally represented during the 9-day tissue collection period wherein one rat was killed per day and subjected to brain microdissection so that crude synaptosomes could be freshly prepared on experiment day. Because of time constraints, only midbrain tissue was flash frozen and processed to make synaptoneurosomes within 1 week to perform Synapto(neuro)some preparation Rats were briefly exposed to CO 2 prior to decapitation and brains were rapidly removed followed by CPu, NAc and midbrain dissection. Midbrain (including VTA and SNc) was flash frozen in 0.32M sucrose. Fresh CPu and NAc synaptosomes were prepared as previously described (Zhen et al. , 2006 . Briefly, striatal subregions were homogenized in ice-cold 0.32 M sucrose at a concentration of 100 mg tissue weight/1.5 mL (15 volumes) with a motor-drive Teflon pestle (800 rpm for 10 strokes). Homogenate was centrifuged at 1000 g for 15 min at 4°C, and the resulting supernatant (S1) was spun at 17 000 g for 20 min at 4°C. Crude synaptosomal pellet (P2) was washed and resuspended at 0.3-1.0 mg/mL protein in modified Krebs uptake buffer (122 mM NaCl, 5.0 mM KCl, 1.0 mM CaCl 2 , 1.2 mM MgSO 4 , 15.0 mM Na 2 HPO 4 , 10 mM glucose, pH 7.4) for functional and binding assays or at 1.0 mg in ice cold DPBS containing 1 mM MgCl 2 and 0.1 mM CaCl 2 (DPBS CM+ , pH 7.4) for DAT biotinylation assay.
Crude synaptoneurosomes from frozen midbrain tissue were prepared as previously described (Hollingsworth et al. 1985; Villasana et al. 2006) . Thawed midbrain tissue was rinsed with ice-cold modified Krebs uptake buffer and then placed in homogenizer containing Krebs buffer at a concentration of 100 mg tissue weight/3.0 mL (30 volumes). Midbrains were carefully homogenized at 300 rpm for 10 strokes using a motor-driven Teflon pestle. Homogenate was passed through a 100 lM filter and then filtered through a 10 lM filter. Resulting homogenate was spun at 1000 g for 15 min. Synaptoneurosomal pellet was washed, spun again and resuspended in modified Krebs uptake buffer for binding and uptake assays. An aliqout of synaptoneurosomes was processed for western blot analysis.
Surface biotinylation of DAT in synaptosomes Synaptosome preparations (1000 lg) were biotinylated with 0.3 mg/mL SulfoLink NHS-SS-biotin (Thermo Scientific) in chilled DPBS-CM 2+ for 1 hr at 4°C followed by centrifugation at 8000 g for 4 min at 4°C. Reaction was terminated by resuspending pellet in ice-cold 100 mM glycine and centrifuged again followed by re-suspension of pellet with glycine and incubating for an additional 15 min at 4°C, end-over-end rotation. Synaptosomes were then washed (39) in cold DPBS. Final pellet of synaptosomes or synaptoneurosomes were sonicated in 1% Triton lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton, 19 protease inhibitors, 1 mM phenylmethylsulfonyl fluoride) and incubated for 1 hr at 4°C, end-over-end rotation. Total lysates were spun at 20 000 g for 20 min at 4°C. Total synaptosomal and synaptoneurosomal preparations were prepared with sample buffer (19 NuPAGE loading buffer and 5% b-mercaptoethanol), heated at 65°C for 10 min and subjected to western blotting procedures. To purify biotinylated surface fraction of synaptosomes, 200 lg of lysate was incubated overnight at 4°C with NeutrAvidin agarose resin (Thermo Scientific). Surface biotinylated proteins were eluted with 100 lL of elution buffer (62.5 mM Tris, pH 6.8, 20% glycerol, 5% b-mercaptoethanol, 2% sodium dodecyl sulfate, SDS) and heated for at 65°C for 10 min. Surface biotinylated fraction alongside total synaptosomal samples (5 lg of CPu and 10 lg of NAc) were separated by 7.5% SDSpolyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. Membranes were probed using goat-anti DAT (sc-1433, 1 : 500; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and antimouse tubulin antibody (1 : 5000; Sigma, St Louis, MO, USA). Secondary antibodies conjugated to horseradish peroxidase were obtained from Pierce (Rockford, IL, USA; 1 : 5000). Immunoblots were developed with Supersignal West Pico and Femto Chemiluminescent Substrate (Thermo Scientific) using a film developer. Band densities were quantified using Image Studio Lite Ver 5.0 following software instructions (LI-COR Biosciences, Lincoln, NE, USA). The amount of DAT surface expression was assessed by determining the relative ratio of biotinylated DAT to total DAT normalized to tubulin levels. Changes in DAT surface or total band densities were expressed as the percentage of AL control for each brain region.
Protein analysis of DATs in synapto(neuro)somes
Total synapto(neuro)somal samples (5 lg, 10 lg, and 45 lg of CPu, NAc and midbrain, respectively) were separated by electrophoresis on precast 4-12% SDS-polyacrylamide gels (Lonza, Rockland, ME, USA) and transferred to a nitrocellulose membrane. cold, rapid vacuum filtration onto a Wallac B filtermats using a Brandel 96-pin manual harvester (Zhen et al. , 2006 . Counts per well were converted to pmol, then corrected to mg of total protein per well and per minute for [ 3 H]DA uptake assays. Kinetic parameters were calculated using Biosoft Kell Radlig software (Cambridge, UK). Tritium accumulation was quantified using a microbeta 1405 liquid scintillation counter. Total radioligand added was assessed using a LS 6500 Multi-Purpose Scintillation Counter, Beckman Coulter, Inc (Fullerton, CA. USA).
Measurement of DA with rotating disk electrode voltammetry
Briefly, synaptosomes were resuspended in ice cold pre-oxygenated physiological buffer (120 mM NaCl, 1.8 mM KCI, 2.5 mM CaCI 2 , 2.3 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 26 mM NaHCO 3 , and 10 mM glucose (pH adjusted to 7.4) (Hagan et al. 2010) . Synaptosomal aliqouts (294 lL) held on ice were added to electrochemical chamber (37°C) with a rotating working electrode (at 4000 rpm) and allowed to equilibrate for 5-10 min. The oxidized DA current (+0.4 V vs. Ag/AgCl reference electrode) was recorded every 300 ms by a National Instruments (Austin, TX, USA) PC interface board. After baseline signal reached a steady state, [DA] was added to the suspension at 37°C to initiate uptake measurement. A range of 0.25 lM to 5.0 lM DA was added to each suspension in chamber. Protein level in each suspension was determined by the Bio-Rad DC protein method. Initial DA uptake (pmol/s/mg) was calculated with the Origin Labtalk program at each tested [DA] . Kinetic parameters (K m and V max ) of uptake were estimated by non-linear fitting of the initial uptake rate to the initial added [DA] according to the Michaelis-Menten equation for saturation (linearly represented by the Scatchard equation) using the Biosoft Kell Radlig software. All results were expressed as mean AE SEM. For insulin studies, synaptosomes were pre-incubated for 15 min at 37°C with or without 30 nM Insulin before assessing DAT-mediated uptake at a concentration of 0.25 lM of DA.
Statistical analysis
There was no blinding of experimenter to diets or to samples processed for biochemical analysis. The design of our biochemical comparison groups was as in our previous biochemical studies. Experimental observations of this type have an overall standard deviation (SD) of 12% (please note that data reported here are average AE SEM). We aimed for being able to detect a difference (d) of at least 25% with p < 0.05 (two-sided, i.e. a = 0.05) with an 80% chance (or power, i.e. b = 0.20), which requires a sample size of at least four in our pharmacology and biochemistry experiments. In most experiments we were able to have a larger sample size and therefore detect differences smaller than 25%. Statistical significance was calculated using Prism software version 6.0 (GraphPad, La Jolla, CA, USA). The threshold for significance employed throughout was p < 0.05, and significance values were calculated by one-way ANOVA with appropriate post hoc tests, or by two-tailed Student's t-test when applicable. Correlations were assessed with the non-parametric Spearman correlation.
Results
Chronic diet manipulation affects rat body weight Prior to initiation of chronic diet regimens, the average body weight of rats was 381.4 AE 4.5 g with no significant differences between groups assigned to the three different diets (p > 0.05). Following 4 weeks of FR or obesogenic (OB) diets, the final and percent change in body weight were found to differ across feeding groups (F 2,57 = 512.5, p < 0.001 and F 2,57 = 524.4, p < 0.001, respectively, Fig. 1a and 1b) . The FR group weighed significantly less than the AL group (305.9 AE 4.1 g vs. 514.5 AE 6.2 g, p < 0.001), with an average weight loss of 25.8 AE 1.3% for FR rats as compared to a 26.1 AE 0.9% weight gain for AL rats. The OB diet resulted in higher body weight than in the AL group (586.7 AE 8.3 g vs. 514.5 AE 6.2 g, p < 0.001), with an average weight increase in 35.1 AE 1.9%. The average increase in body weight of OB over AL rats was found to be approximately 12.0 AE 1.2% (p < 0.001). We have previously shown that these three diets, applied for a Fig. 1 Final body weight (a) and change in body weight over time (b) as a function of chronic food restriction (FR) and an obesogenic diet (OB) diet compared to ad libitum (AL) feeding. Data are means AE SEM for 20 rats, **p < 0.0001 versus AL control (one-way ANOVA followed by Dunnett's post hoc test). similar duration to this study, lead to markedly different levels of circulating insulin (Stouffer et al. 2015) .
Chronic FR or OB diet reduced basal dopamine uptake V max in the CPu, whereas NAc and midbrain showed a different pattern of effects To assess whether diet is linked to changes in DAT function, we examined DAT kinetic parameters (V max and K m ) in CPu and NAc synaptosomes using rotating disk electrode voltammetry (RDEV), a direct measure of DA uptake in real time. Because DAT in the midbrain resides on somatodendrites of DA cell bodies and is expressed at a much lower level than in the striatum (Cragg et al. 1997; Hoffman et al. 1998; Chen and Rice 2001; Keller et al. 2011) , the more sensitive classical [ 3 H]DA uptake approach was used for kinetic resolution of DAT function in midbrain synaptoneurosomes.
Consistent with known expression differences in DAT in striatal subregions (Marshall et al. 1990; Coulter et al. 1995) , we found that DA uptake V max in AL rats was higher by 55% in the CPu than in the NAc with a similar K m (Fig. 2, Table 1 ). Although absolute V max and K m values cannot be compared between RDEV and [ 3 H]DA uptake assays, the greatly reduced maximal uptake rate observed per mg midbrain tissue relative to that in striatum (Fig. 2 ) is in accordance with its low DAT expression (Cragg et al. 1997; Hoffman et al. 1998; Chen and Rice 2001; Keller et al. 2011) .
Examination of dieted animals revealed a significant effect on DA uptake in the CPu with little to no effect in the NAc and midbrain. Specifically, rats on either a FR or obesogenic (OB) diet displayed reduced DA uptake (V max ) in CPu synaptosomes by an average of 25% with no change in K m (Table 1 ) compared to AL fed rats (Fig. 2) in Fig. 3 , the absolute B max values in CPu of AL rats were approximately 2-and 10-fold higher than those in NAc and midbrain, respectively, consonant with previous findings showing regional differences in DAT expression (Coulter et al. 1995; Cragg et al. 1997; Hoffman et al. 1998; Chen and Rice 2001; Keller et al. 2011) .
As observed for DA uptake V max , the absolute B max values in CPu synaptosomes harvested from FR and OB rats were reduced by~25%, when compared with AL rats (Fig. 3) (F 2,14 = 5.079, p = 0.022). In NAc synaptosomes and midbrain synaptoneurosomes, B max values (Fig. 3) appeared to follow a similar trend as V max (Fig. 2) Fig. 4) . For the latter, surface biotinylated DAT was reduced by~25% across the FR and OB groups compared to AL (Fig. 4b ) in parallel to the~25% reductions in B max of [ 3 H]CFT binding (Fig 3) . Although surface DAT showed no significant effects in the NAc, a pattern similar to that displayed by binding B max response to diet was observed.
These decreases in CPu B max were reminiscent of the 25% reductions in DA uptake V max , prompting the question as to whether diet regulates the number of surface DATs rather than the uptake rate of each individual DAT. To this end, we compared V max values to matched B max values obtained on the same tissues across all diet groups in each (sub)region using Spearman correlation coefficients. As shown in Fig. 5 , significant linear correlations were obtained between B max and V max values, indicating that V max values fluctuate in accordance with DAT surface expression. As an additional factor, we found no significant correlations between kinetic measures and weight of animals within each diet group at time of sacrifice (data not shown). Taken together, the results indicate that DAT regulation in response to diet occurs at the level of DAT surface expression in CPu, NAc and midbrain.
Insulin enhances DA uptake as a function of diet in striatal subregions Chronic insulin manipulation through diet affects DAT density at the cell surface and thus overall DA uptake capacity, and therefore we investigated whether DA uptake would be affected by acute exogenous insulin addition using RDEV. Examination of midbrain synaptoneurosomes was not performed given methodological factors of RDEV and tissue availability. In striatal synaptosomes from dieted rats, we examined the relative change in uptake with and without insulin. Relative changes of 0.25 lM DA uptake in response to 30 nM insulin was compared to baseline. DAT-mediated uptake showed a significant increase in CPu synaptosomes (137 AE 5.0% of baseline in AL, 171 AE 8.7% of baseline in FR, and 121 AE 7.8% in OB) (Fig. 6, left panel) . A similar trend was observed in NAc synaptosomes with a loss of insulin's effect on DA uptake in OB rats (121 AE 3.3% of baseline in AL, 135 AE 5.5% of baseline in FR, and 105 AE 6.6% in OB) (Fig. 6, right panel) . Comparison of insulin's effect on DA uptake revealed that FR significantly enhanced insulin-induced DA uptake in both CPu (71% vs. 37% in AL, p < 0.05) and NAc (35% vs. 21% in AL, p < 0.05), whereas OB diet attenuated this effect only in the NAc (21% vs. 5% in AL, p < 0.05). Moreover, comparison of insulin's effect on DA uptake between CPu and NAc in AL animals revealed possible regional differences in DA uptake rate changes. This finding is at odds with the fact that InsR expression is higher in the NAc than in the CPu (Schulingkamp et al. 2000) and the general ability of InsRs, when activated, to enhance DAT surface expression and thereby DA uptake capacity. A possible reason is the higher expression of D 2 Rs in the CPu.
Diet regionally affects total DAT, InsR, and D 2 R expression in synapto(neuro)somes Activation of D 2 Rs or InsRs can exert a DA uptake enhancing effect by mediating an increase in surface DAT (Mayfield and Zahniser 2001; Bolan et al. 2007; Lee et al. 2007; Owens et al. 2012) . Therefore, we assessed the levels of these two regulatory proteins, as well as DAT itself for possible diet-induced changes in expression. Western blot analysis of CPu synaptosomal lysates from FR rats revealed a significant increase in InsR (118 AE 4.2%) with no change in total DAT or D 2 R expression, whereas OB rats showed a reduction in total DAT (81 AE 4.2%) and D 2 R (72 AE 1.6%) with no change in InsR expression compared to AL rats (Fig. 7) . The finding that total DAT levels were reduced in CPu synaptosomes from OB rats may account for lowered surface expression compared with AL rats (Fig. 4) . A different mechanism is at play in FR rats in which total DAT is unchanged relative to AL rats despite a reduction in surface DAT (Fig. 4) . Lysates from NAc synaptosomes of FR rats show elevated InsR (114 AE 3.5%) and D 2 R (131 AE 12.1%) expression with no significant effect on total DAT density. In contrast, the obesogenic diet had no significant effect on DAT, D 2 R and InsR expression in the NAc. In the midbrain, diet appeared to influence the expression of these proteins with a pattern similar to that seen in the NAc but the effects were not statistically significant (Fig. 7) . Given the heterogeneity of neuron type and D 2 R localization in the tissue homogenates, it will be important to investigate whether D 2 R autoreceptors contribute to changes in DAT surface expression and subsequent function with insulin.
Discussion
Long-term changes in DAT would be expected to influence feeding and drug-induced behaviors. It is known that FR and OB diets increase or decrease, respectively, the rewarding and locomotor-activating effects of drugs of abuse that target the DAT (Carroll et al. 1981; Pothos et al. 1995; Bell et al. 1997; Cabeza de Vaca and Carr 1998; Davis et al. 2008; Carr 2011; Speed et al. 2011; Zheng et al. 2012; Hryhorczuk et al. 2016) . We hypothesized that circulating insulin regulates DAT function in the subregions of striatum and midbrain, and therefore sought relationships between DAT expression and function, DAT sensitivity to modulation by insulin, and InsR expression in AL, OB, and FR diet groups. Accordingly, we found altered properties of DAT in the CPu of OB and FR subjects but no significant changes in the NAc or midbrain. Our results indicate that reduced uptake capacity (V max ) in the CPu can be explained by changes in cell surface expression as determined by biotinylation and B max of [ 3 H] CFT binding. These findings, in addition to unchanged DA affinity (K m ), support a model whereby diet-induced reduction in DAT activity in the CPu is a result of lowered surface expression rather than a change in transport activity of individual DAT molecules. Moreover, we provide evidence that chronic diet manipulations lead to distinctive adaptations of DAT in the CPu versus NAc or midbrain which support regional variability on DAT regulation (Kokoshka et al. 1998; Gulley et al. 2002; Richards and Zahniser 2009; Siciliano et al. 2014) .
The seeming paradox of FR and OB diets both lowering basal activity of DAT in the CPu can potentially be explained by low circulating insulin in the former and high circulating insulin in the latter (Strubbe et al. 1988; Stouffer et al. 2015) . Chronic hypoinsulinemia would be associated with understimulation of InsRs and hyperinsulinemia would be associated with a compensatory decrease in InsR sensitivity, as seen in our voltammetry studies (Stouffer et al. 2015) . Either way, reduced InsR signaling through the PI3K/Akt pathway would weaken insulin's normal effect of maintaining DAT surface presence. Here our findings support those of others that showed reduced DAT function in CPu or striatal preparations by food deprivation and restriction (Patterson et al. 1998; Zhen et al. 2006) , streptozotocin treatment (Owens et al. 2005; Williams et al. 2007) , or obesogenic diets (Speed et al. 2011) . Importantly, function in food deprived and streptozotocin-treated subjects was restored by insulin replacement (Patterson et al. 1998; Williams et al. 2007) . However, while diet-related changes in insulin exposure and InsR sensitivity are presumably the same in NAc and midbrain as in CPu, there were no observable effects of diet on basal DAT activity in the NAc or midbrain. This would either suggest that insulin is not the regulator of DAT function in CPu or that DAT regulatory mechanisms differ between brain regions. Although previous studies are in accordance with our findings showing unchanged DAT in NAc of FR subjects (Patterson et al. 1998; Zhen et al. 2006) , others have shown that FR with scheduled sucrose access led to DAT increases in the NAc shell but not NAc core (Lindblom et al. 2006) and VTA not SNc (Bello et al. 2003) . With obesogenic diets, Cone et al. (2013) reported no change in the mature 80 kDA isoform of DAT in NAc, in agreement with present results, whereas others showed reduced function (Narayanaswami et al. 2013; Hryhorczuk et al. 2016) . Thus, distinctive adaptations of DAT may occur within striatal and midbrain subregions, based on different regulatory mechanisms and the type and duration of diet. In regard to the latter, the absence of effect of OB diet on NAc DAT in this study conflicts with previous reports (Cone et al. 2013; Narayanaswami et al. 2013; Hryhorczuk et al. 2016) . It is possible that supplementation of chow feeding with Ensure was not sufficient to induce significant DAT changes in the NAc, due either to the limited duration of Ensure feeding and/or the amount of excess body weight gained. Indeed, the difference in body weight between AL and OB animals ( Fig. 1) failed to meet the conventional criteria for obesity (15-20%) (Levin and Keesey 1998; Madsen et al. 2010) . However, we have previously shown that the 4-week diet regimen of Ensure decreased striatal evoked DA release (Stouffer et al. 2015) and abolished insulin receptor-mediated signaling in the striatum (Woods et al. 2016) , both of which are associated with obesity (Johnson and Kenny 2010; Stouffer et al. 2015) , and indicate physiologically important adaptations of the DA system in the absence of any change in the DAT.
Changes in DAT function with diet are often directly related to surface expression (Kahlig et al. 2004; Melikian 2004; Zahniser and Sorkin 2004) . However, Narayanaswami et al. (2013) showed in obese rats that reduction in DA uptake V max in NAc was specifically independent from DAT trafficking as there was no accompanying reduction in biotinylated surface DAT. The discrepancy may lie in the high-fat diet used to promote obesity versus the moderate fat and sugar diet conditions used in the present work. It is becoming apparent that diet composition can be crucial, even within high-fat diets . Previous evidence suggests that diet effects and/or insulin action at InsRs in the NAc may also affect catalytic properties of DAT (Carvelli et al. 2002; Garcia et al. 2005; Williams et al. 2007 ) in addition to mediating DAT trafficking to the plasma membrane via PI3K/Akt-mediated signaling (Garcia et al. 2005; Speed et al. 2011) .
Support for insulin regulation of DAT trafficking and/or function in both CPu and NAc stems from insulin-stimulated potentiation of DAT uptake as a function of diet. The acute effect of 30 nM insulin on DA uptake was measured in CPu and NAc at a concentration of DA below K m for uptake (Fig. 7) . Therefore, uptake changes could be because of alterations in K m or V max or both. Notably, this functional response to insulin was enhanced in CPu and NAc of FR rats compared to AL rats, consonant with InsR over-expression and/or hypersensitivity with FR diet. With OB diet, insulin's potentiating effect on DAT activity was blocked in the NAc, but not in CPu compared to AL and FR rats, likely as a result of InsR subsensitivity as recently demonstrated to occur in the NAc of OB rats subjected to the same diet (Woods et al. 2016) . Changes in InsR sensitivity as a consequence of diet contributes, at least partially, to both rapid and long term regulation of DAT function in a regionally dependent manner. As mentioned, the subregional effects of insulin with DAT further support distinct regulatory mechanisms important in modulating DAT function.
Insulin action in the brain contributes to many important processes (see review; Daws et al. 2011 ) some of which could have a direct or indirect effect on the activity and Fig. 7 Effect of food restriction (FR) and obesogenic diet (OB) diets on expression of dopamine transporter (DAT), insulin receptor (InsR), and dopamine 2 receptor (D 2 R) in a regionally specific manner. Shown are representative immunoblots depicting synapto (neuro)somal protein levels and corresponding protein band intensities that are normalized to the level of tubulin and expressed as % change relative to ad libitum (AL) control in each brain (sub) region (means AE SEM for 4-7 independent experiments, *p < 0.05 versus AL control, one-way ANOVA followed by Dunnett's post hoc test).
availability of DAT at the cell surface. One mechanism involves insulin's role in regulating the release of DA. Our group has demonstrated the effect of InsR signaling in regulating electrically evoked DA release in the CPu and NAc (Stouffer et al. 2015) . Results obtained using ex vivo voltammetry included reductions in evoked DA release in striatal subregions of FR and OB rats compared to AL rats (for direct comparison with DA uptake changes in CPu under the same diet conditions see Table S1 ). Notably, addition of nM concentrations of insulin increased evoked DA release that was enhanced in FR rats, but blunted in OB rats. Such changes in DA signals could lead to compensatory changes in DAT and its associated D 2 R autoreceptor. Indeed, we found differential alteration of D 2 R expression with OB and FR diets (Fig. 7) . D 2 R activation is known to enhance DAT activity (Meiergerd et al. 1993; Mayfield and Zahniser 2001; Bolan et al. 2007 ) and promote increased cell surface DAT, possibly via ERK1/2 activation (Moron et al. 2003; Bolan et al. 2007) or direct interaction (Lee et al. 2007 ). Thus, dietinduced changes in total D 2 Rs are speculated to include changes in the pre-synaptic D 2 Rs regulating DAT which may factor into the overall transport capacity of DAT at baseline.
Further evidence for a positive correlation between D 2 R activity and membrane-associated DAT was shown by Owens et al. (2012) wherein repeated stimulation of D 2 R [by increasing DA levels with amphetamine (AMPH)] led to restoration of DAT function in hypoinsulinemic rats. Thus, the D 2 R down-regulation seen in CPu of OB rats may contribute to the observed decrease in DAT function, though the up-regulation of D 2 R in NAc of FR rats does not easily fit with the unchanged DAT surface expression and kinetics. Yet, it is important to consider that D 2 R actions also control other aspects of DA transmission by both pre-and postsynaptic pathways (Baik 2013; Ford 2014 ) thereby presenting a challenge in assigning D 2 R function. Therefore, future studies should aim to better elucidate the cellular and molecular role of D 2 Rs in the regulation of DA transmission given that synapto(neuro)somes contain different subpopulations of cells.
Earlier studies agree with our findings and extend the conclusion that diet duration and composition have effects on D 2 R expression (Naef et al. 2015) , and altered behavioral responses to DA are mediated, in part, by D 2 R. D 2 Rs were found to be supersenstitive in NAc of FR rats as evidenced by increased locomotor activation in response to the D 2 R agonist quinpirole (Carr et al. 2003) , which was confirmed in two later studies reporting on the locomotor effect of pramipexole (Collins et al. 2008 ) and binding of spiperone by autoradiography (Thanos et al. 2008) . In obese rats, D 2 R levels were found to be reduced in the striatal complex (Johnson and Kenny 2010) including CPu (Colantuoni et al. 2001) , NAc (Thanos et al. 2008) and in the NAc shell (Hajnal et al. 2008 ) along with decreased susceptibility to the behavioral effect of the D 2 R agonist quinpirole (Hajnal et al. 2008; Fordahl et al. 2016) . These findings also fit with the behavioral effects of DAT ligands which are enhanced by FR diet (Bell et al. 1997; Cabeza de Vaca and Carr 1998; Carr 2011; Zheng et al. 2012) and decreased by OB diet (Wellman et al. 2007; Davis et al. 2008; Speed et al. 2011; Hryhorczuk et al. 2016) . Given our finding of insulin's acute effect on DAT function in a diet-and region-dependent manner, it will be of interest to investigate a possible role for this mechanism, in addition to D 2 R signaling, in mediating the behavioral effects of psychostimulants. This could have implications for other DAT substrates and associated physiological effects since Siciliano et al. (2014) reported that maximal uptake rates of DAT (V max ) are positively correlated with AMPH potency. Interestingly, a recent study by Fordahl et al. (2016) found that repeated administration of AMPH to high fat-fed mice led to increased AMPH potency despite reduced DA uptake and unaltered sensitivity of D 2 R autoreceptors to the release-inhibitory effect of quinpirole, suggesting that other mechanism(s) involving DAT dysregulation are at play.
Taking into account our findings that various components of the DA system are modifiable by diet in a region-specific manner, it is of interest to speculate how this translates into different behavioral outcomes depending on the DA circuit involved. The mesolimbic pathway includes projection of DA neurons from VTA to NAc and is important for mediating the rewarding and reinforcing effects of drugs of abuse (Di Chiara and Imperato 1988; Kelley and Berridge 2002; Volkow and Wise 2005) and palatable foods (Kelley 2004; Roitman et al. 2004; Stouffer et al. 2015) . Regarding the latter, the results obtained by Stouffer et al. (2015) and Woods et al. (2016) indicate that insulin in the NAc is important in establishing a memory of a meal's rewarding qualities and nutrient value complementary to the hypothalamic and VTA satiety signals provided by insulin for ending a meal (Schulingkamp et al. 2000; Vogt and Bruning 2013) . In the NAc, our findings that chronic FR causes higher D 2 R expression but unaltered DAT, together with previous reports of reduced tonic levels of DA (Pothos et al. 1995) and lowered evoked DA release (Stouffer et al. 2015) , suggest that up-regulated D 2 R could play a presynaptic role in dampening release, and a post-synaptic role in amplifying the response to phasically released DA. This would have the adaptive effect of conserving organismic energy expenditure under basal conditions but could ensure a normal or amplified behavioral response to salient DA-releasing stimuli such as food and associated cues. Drugs of abuse that induce a DA surge would similarly 'benefit' from the upregulation of post-synaptic signaling.
The parallel nigrostriatal DA pathway tracks from SNc to the CPu and plays a role in action selection (Grillner et al. 2013) , habit-based behaviors (Everitt and Robbins 2005) and drug craving (Volkow et al. 2006; Koob and Volkow 2010) . The reduced D 2 R observed in the CPu of OB rats extend previous findings by Narayanaswami et al. (2013) and is consistent with the idea that perpetuation of excessive eating may be a response to an acquired 'reward deficiency syndrome' (Wang et al. 2001; Volkow and Wise 2005; Johnson and Kenny 2010) . Thus, D 2 R down-regulation seen in OB diets is thought to drive compulsive eating behaviors (Wang et al. 2001; Volkow and Wise 2005; Johnson and Kenny 2010) . Furthermore, it is thought that development of addiction involves a transition in DA control from NAc to CPu (Everitt and Robbins 2005) . It is conceivable that the lower DA levels, DAT, and D 2 R observed with OB diet in CPu would make a subject less vulnerable to this maladaptive transition when psychostimulant use is concurrent with OB diet.
Taken together, our present and prior results (Stouffer et al. 2015) support a model in which CPu DA adaptations to FR and OB diets include decreased expression and function of the DAT, possibly secondary to a sustained decrease in InsR signaling and/or D 2 R tone. NAc adaptations to these diets are clearly present, in the form of altered DA release, InsR expression and sensitivity, and post-synaptic signaling, but do not appear to include direct effects on DAT expression or function. The reason(s) for differential modulation of DAT in CPu and NAc by the present dietary treatments is not clear, and we cannot rule out the possibility that DAT changes in CPu and NAc emerge at different latencies and would be similar after a longer duration of maintenance on these same experimental diets. However, with regard to diet-induced changes in the rewarding and reinforcing effects of psychostimulants that target the NAc DAT, current and prior results point away from their primary molecular target, the DAT, and toward DA release and upregulated post-synaptic signaling as mechanistic bases of altered behavioral effects.
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